RecruitingNCT06490926
NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome
Sponsor
Fujian Medical University Union Hospital
Enrollment
180 participants
Start Date
Feb 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
At present, the diagnosis of Parkinsons disease(PD) mainly relies on clinical symptoms and is easily confused with atypical Parkinsonian syndrome(APS) in the early stages. There is an urgent need for reliable biomarkers. This project aims to use metabolomics technology based on proton nuclear magnetic resonance spectroscopy to study the metabolomic characteristics of patients with PD and APS, and preliminarily screen for possible diagnostic biomarkers of PD and APS.
Eligibility
Min Age: 45 YearsMax Age: 80 Years
Inclusion Criteria12
- Age range from 45 to 80 years old;
- Age range from 45 to 80 years old;
- Meets the Chinese expert consensus on the diagnostic criteria for multiple system atrophy (2017) or the International Society for Parkinson\'s Disease and Movement Disorders (MDS) diagnostic criteria for multiple system atrophy (2022)
- ③ MSA subtype grouping: MSA is divided into MSA-P and MSA-C subtypes based on the severity of initial and/or motor symptoms, with Patients with Parkinson\'s syndrome as the main type are MSA-P, while patients with cerebellar syndrome as the main type are MSA-C.
- Age range from 45 to 80 years old;
- ② PSP patients who meet the diagnostic criteria for progressive supranuclear palsy in China (2016) or the diagnostic criteria for progressive supranuclear palsy in the International Society for Parkinson\'s Disease and Movement Disorders (MDS) (2017)
- (3) Selection criteria for Parkinson\'s disease case group
- Age range from 45 to 80 years old;
- Patients with idiopathic Parkinson\'s disease who meet the diagnostic criteria of the International Committee on Motor Disorders (MDS) for Parkinson\'s disease (2015);
- Classification criteria for subtypes of Parkinson\'s disease:
- Tremor predominant type: According to the MDS-UPDRS score, the ratio of average tremor score to average PIGD score is ≥ 1.15
- PIGD type: According to the MDS-UPDRS score, the ratio of average tremor score to average PIGD score is ≤ 0.9
Exclusion Criteria3
- ① Hereditary Parkinson\'s syndrome, secondary Parkinson\'s syndrome.
- After deep brain stimulation (DBS) surgery.
- Have a history of malignant tumors.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06490926
Related Trials
[18F]F-DOPA Imaging in Patients With Autonomic Failure
NCT042464371 location
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
NCT0207113484 locations
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study
NCT072169765 locations
Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
NCT073860151 location
Imaging Depression in Parkinson's Disease
NCT064029551 location